Hypera (HYPMY) News Today $3.13 +0.09 (+2.80%) As of 03:50 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Hypera (OTCMKTS:HYPMY) Stock Crosses Above 50-Day Moving Average - Here's WhyHypera (OTCMKTS:HYPMY) Share Price Passes Above 50-Day Moving Average - Time to Sell?January 25, 2025 | marketbeat.comHypera (OTCMKTS:HYPMY) Stock Passes Below 50-Day Moving Average - Should You Sell?Hypera (OTCMKTS:HYPMY) Share Price Passes Below Fifty Day Moving Average - Here's What HappenedJanuary 9, 2025 | marketbeat.comShort Interest in Hypera S.A. (OTCMKTS:HYPMY) Rises By 28.4%Hypera S.A. (OTCMKTS:HYPMY - Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 14,900 shares, an increase of 28.4% from the November 30th total of 11,600 shares. Based on an average trading volume of 50,400 shares, the short-interest ratio is currently 0.3 days.December 29, 2024 | marketbeat.comHypera (OTCMKTS:HYPMY) Share Price Passes Below 200-Day Moving Average - Should You Sell?Hypera (OTCMKTS:HYPMY) Shares Cross Below Two Hundred Day Moving Average - Here's What HappenedDecember 26, 2024 | marketbeat.comHypera (OTCMKTS:HYPMY) Reaches New 52-Week Low - Time to Sell?Hypera (OTCMKTS:HYPMY) Sets New 52-Week Low - Here's What HappenedDecember 18, 2024 | marketbeat.comHypera: Short-Term Pain For Long-Term GainNovember 26, 2024 | seekingalpha.comHypera S.A. Reports Strategic Shift Amid Revenue DeclineNovember 15, 2024 | markets.businessinsider.comNature’s ‘Swiss Army Knife’: What Can We Learn From Venom?November 13, 2024 | nytimes.comBrazil's Hypera rejects EMS merger offer offer on 'significant' undervaluationOctober 25, 2024 | reuters.comShort Interest in Hypera S.A. (OTCMKTS:HYPMY) Increases By 33,554.8%Hypera S.A. (OTCMKTS:HYPMY - Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 2,086,600 shares, a growth of 33,554.8% from the September 30th total of 6,200 shares. Based on an average daily trading volume, of 2,231,900 shares, the days-to-cover ratio is presently 0.9 days.October 25, 2024 | marketbeat.comEMS offers to buy Hypera for R$30 per share, Brazil Journal reportsOctober 23, 2024 | markets.businessinsider.comHypera confirms acquisition proposal received from EMSOctober 23, 2024 | markets.businessinsider.comBrazil pharmaceutical firm EMS offers to combine with rival HyperaOctober 22, 2024 | reuters.comHypera (OTCMKTS:HYPMY) Sets New 1-Year Low - Time to Sell?Hypera (OTCMKTS:HYPMY) Sets New 52-Week Low - Here's WhyOctober 17, 2024 | marketbeat.com7 Turmeric Health Benefits for Women, Backed by ScienceOctober 11, 2024 | msn.comHypera SA (HYPMY) Q2 2024 Earnings Call Highlights: Strong Cash Flow and Strategic R&D ...October 10, 2024 | finance.yahoo.comHypera S.A. (OTCMKTS:HYPMY) Sees Large Increase in Short InterestHypera S.A. (OTCMKTS:HYPMY - Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 6,200 shares, an increase of 6,100.0% from the September 15th total of 100 shares. Based on an average daily volume of 11,200 shares, the short-interest ratio is presently 0.6 days.October 10, 2024 | marketbeat.comZealand Pharma: FDA Issues CRL For Dasiglucagon In Congenital HyperinsulinismOctober 9, 2024 | markets.businessinsider.comAligos Therapeutics' ALG-055009 Trial Met Primary Goal In MASH; In Talks For Fund; Stock DropsSeptember 19, 2024 | markets.businessinsider.comHypera (OTCMKTS:HYPMY) Shares Cross Below 200-Day Moving Average of $5.65Hypera (OTCMKTS:HYPMY) Share Price Passes Below Two Hundred Day Moving Average of $5.65September 19, 2024 | marketbeat.comScientists pinpoint subtle changes that may signal risk of Alzheimer'sSeptember 18, 2024 | msn.comMeta-analysis provides insight into disrupted brain networks in behavioral addictionsSeptember 16, 2024 | msn.comHypera (OTCMKTS:HYPMY) Stock Price Passes Above 50 Day Moving Average of $5.28Hypera (OTCMKTS:HYPMY) Shares Cross Above 50 Day Moving Average of $5.28August 23, 2024 | marketbeat.comThis popular hair growth ingredient doesn’t really work — experts share what to use insteadAugust 16, 2024 | msn.comStruggling with hair loss? Experts say you should look for these ingredientsAugust 16, 2024 | msn.comHypera S.A. (OTCMKTS:HYPMY) Short Interest Up 63.3% in JulyHypera S.A. (OTCMKTS:HYPMY - Get Free Report) was the recipient of a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 4,900 shares, a growth of 63.3% from the July 15th total of 3,000 shares. Based on an average daily trading volume, of 5,300 shares, the short-interest ratio is currently 0.9 days.August 14, 2024 | marketbeat.comGlytec Recognizes CMS for New Mandatory Hyper- and Hypoglycemia Measures for U.S. HospitalsAugust 6, 2024 | finance.yahoo.comToddler 'turned grey and passed out' after drinking Slush PuppieAugust 2, 2024 | msn.comCan You Have Both Hyperthyroidism And Hypothyroidism?August 1, 2024 | msn.comHYPMY Stock Earnings: Hypera Reported Results for Q2 2024July 26, 2024 | investorplace.comSticky attention in autism: Scientists make unexpected discovery when analyzing eye-tracking dataJuly 23, 2024 | msn.comAn over- or under-synchronized brain may predict psychosisJuly 22, 2024 | msn.com7 clever ways to motivate your lazy dog to exerciseJuly 19, 2024 | msn.comShort Interest in Hypera S.A. (OTCMKTS:HYPMY) Expands By 47.7%Hypera S.A. (OTCMKTS:HYPMY - Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 16,400 shares, an increase of 47.7% from the June 15th total of 11,100 shares. Based on an average daily trading volume, of 15,400 shares, the days-to-cover ratio is currently 1.1 days.July 13, 2024 | marketbeat.comHyperthyroidism second most common endocrine disease in Malaysia, warns doctorMay 27, 2024 | msn.comHypera SA HYPE3May 18, 2024 | morningstar.comBulging EyesMay 15, 2024 | msn.comWhat are sensory preferences? How eight senses can explain fussy eatingApril 28, 2024 | bbc.co.ukNicole Kidman hailed for guidance, love and sisterhood as star honoured by AFIApril 28, 2024 | msn.comWays Diabetics Can Travel Abroad OptimallyApril 26, 2024 | msn.comChaitra Navratri 2024: 5 Fasting Rules For Diabetics to Ensure Stable Blood Sugar LevelsApril 8, 2024 | msn.comFact Check: Many Believe Sugar Makes Kids Hyperactive. Here's What the Science SaysApril 3, 2024 | yahoo.comPhysiology Expert Reveals the Truth About Drinking Water and Fat LossApril 2, 2024 | msn.comWarning Signs You May Be Suffering From Hypothyroidism Without Knowing ItMarch 31, 2024 | msn.comHypera SA's Dividend AnalysisMarch 22, 2024 | finance.yahoo.comHypera SA ADR HYPMYMarch 20, 2024 | morningstar.comAutism in adults: Signs of autism spectrum disorder as you get olderMarch 18, 2024 | msn.comHYPMY Hypera S.A.March 16, 2024 | seekingalpha.comMan Allegedly Received Over 200 COVID-19 Vaccinations — and It Didn't Negatively Affect His Immune System, Researchers SayMarch 7, 2024 | ca.sports.yahoo.com10 Signs You Should Pay More Attention To Your Thyroid HealthFebruary 20, 2024 | msn.com Get Hypera News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPMY and its competitors with MarketBeat's FREE daily newsletter. Email Address HYPMY Media Mentions By Week HYPMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HYPMY News Sentiment▼0.670.74▲Average Medical News Sentiment HYPMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HYPMY Articles This Week▼21▲HYPMY Articles Average Week Get Hypera News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Jazz Pharmaceuticals News Today Blueprint Medicines News Today Shiseido News Today Madrigal Pharmaceuticals News Today BridgeBio Pharma News Today Legend Biotech News Today Elanco Animal Health News Today Corcept Therapeutics News Today Telix Pharmaceuticals Limited American Depositary Shares News Today Cytokinetics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HYPMY) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hypera S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hypera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
